In new independent research reports released early this morning,
Market Source Research released its latest key findings for all
current investors, traders, and shareholders of Schlumberger N.V.
(NYSE:SLB), W.W. Grainger, Inc. (NYSE:GWW), Best Buy Co., Inc.
(NYSE:BBY), Acadia Realty Trust (NYSE:AKR), Keryx
Biopharmaceuticals, Inc. (NASDAQ:KERX), and Gannett Co., Inc.
(NYSE:GCI), including updated fundamental summaries, consolidated
fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available
to readers at the links below.
SLB DOWNLOAD:
http://MarketSourceResearch.com/register/?so=SLB GWW DOWNLOAD:
http://MarketSourceResearch.com/register/?so=GWW BBY DOWNLOAD:
http://MarketSourceResearch.com/register/?so=BBY AKR DOWNLOAD:
http://MarketSourceResearch.com/register/?so=AKR KERX DOWNLOAD:
http://MarketSourceResearch.com/register/?so=KERX GCI DOWNLOAD:
http://MarketSourceResearch.com/register/?so=GCI
(You may have to copy and paste the link into your browser and
hit the [ENTER] key)
The new research reports from Market Source
Research, available for free download at the links above, examine
Schlumberger N.V. (NYSE:SLB), W.W. Grainger, Inc. (NYSE:GWW), Best
Buy Co., Inc. (NYSE:BBY), Acadia Realty Trust (NYSE:AKR), Keryx
Biopharmaceuticals, Inc. (NASDAQ:KERX), and Gannett Co., Inc.
(NYSE:GCI) on a fundamental level and outlines the overall demand
for their products and services in addition to an in-depth review
of the business strategy, management discussion, and overall
direction going forward. Several excerpts from the recently
released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following
excerpts are not designed to be standalone summaries and as such,
important information may be missing from these samples. Please
download the entire research report, free of charge, to ensure you
are reading all relevant material information. All information in
this release was accessed November 27th, 2017. Percentage
calculations are performed after rounding. All amounts in millions
(MM), except per share amounts.
-----------------------------------------
Schlumberger N.V. (SLB) REPORT OVERVIEW
Schlumberger N.V's Recent Financial
Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, Schlumberger N.V reported revenue of
$7,905.00MM vs $7,019.00MM (up 12.62%) and basic earnings per share
$0.39 vs $0.13 (up 200.00%). For the twelve months ended December
31st, 2016 vs December 31st, 2015, Schlumberger N.V reported
revenue of $27,810.00MM vs $35,475.00MM (down 21.61%) and basic
earnings per share -$1.24 vs $1.63. Schlumberger N.V is expected to
report earnings on January 19th, 2018. The report will be for the
fiscal period ending December 31st, 2017. The reported EPS for the
same quarter last year was $0.27. The estimated EPS forecast for
the next fiscal year is $2.13 and is expected to report on January
19th, 2018.
To read the full Schlumberger N.V. (SLB) report, download it
here:
http://MarketSourceResearch.com/register/?so=SLB
-----------------------------------------
W.W. Grainger, Inc. (GWW) REPORT OVERVIEW
W.W. Grainger's Recent Financial
Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, W.W. Grainger reported revenue of
$2,636.00MM vs $2,596.29MM (up 1.53%) and basic earnings per share
$2.80 vs $3.07 (down 8.79%). For the twelve months ended December
31st, 2016 vs December 31st, 2015, W.W. Grainger reported revenue
of $10,137.20MM vs $9,973.38MM (up 1.64%) and basic earnings per
share $9.94 vs $11.69 (down 14.97%). W.W. Grainger is expected to
report earnings on January 24th, 2018. The report will be for the
fiscal period ending December 31st, 2017. The reported EPS for the
same quarter last year was $2.45. The estimated EPS forecast for
the next fiscal year is $11.06 and is expected to report on January
24th, 2018.
To read the full W.W. Grainger, Inc. (GWW) report, download it
here:
http://MarketSourceResearch.com/register/?so=GWW
-----------------------------------------
Best Buy Co., Inc. (BBY) REPORT OVERVIEW
Best Buy Co.'s Recent Financial Performance
For the three months ended July 31st, 2017 vs
July 31st, 2016, Best Buy Co. reported revenue of $8,940.00MM vs
$8,533.00MM (up 4.77%) and basic earnings per share $0.69 vs $0.62
(up 11.29%). For the twelve months ended January 31st, 2017 vs
January 31st, 2016, Best Buy Co. reported revenue of $39,403.00MM
vs $39,528.00MM (down 0.32%) and basic earnings per share $3.86 vs
$2.59 (up 49.03%). Best Buy Co. is expected to report earnings on
March 7th, 2018. The report will be for the fiscal period ending
January 31st, 2018. The reported EPS for the same quarter last year
was $1.95. The estimated EPS forecast for the next fiscal year is
$4.26 and is expected to report on March 7th, 2018.
To read the full Best Buy Co., Inc. (BBY) report, download it
here:
http://MarketSourceResearch.com/register/?so=BBY
-----------------------------------------
Acadia Realty Trust (AKR) REPORT OVERVIEW
Acadia Realty Trust's Recent Financial
Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, Acadia Realty Trust reported revenue of
$62.68MM vs $43.86MM (up 42.92%) and basic earnings per share $0.15
vs $0.08 (up 87.50%). For the twelve months ended December 31st,
2016 vs December 31st, 2015, Acadia Realty Trust reported revenue
of $215.77MM vs $215.67MM (up 0.05%) and basic earnings per share
$0.94 vs $0.94 (unchanged). Acadia Realty Trust is expected to
report earnings on February 13th, 2018. The report will be for the
fiscal period ending December 31st, 2017. The reported EPS for the
same quarter last year was $0.39. The estimated EPS forecast for
the next fiscal year is $1.53 and is expected to report on February
13th, 2018.
To read the full Acadia Realty Trust (AKR) report, download it
here:
http://MarketSourceResearch.com/register/?so=AKR
-----------------------------------------
Keryx Biopharmaceuticals, Inc. (KERX) REPORT
OVERVIEW
Keryx Biopharmaceuticals' Recent Financial
Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, Keryx Biopharmaceuticals reported revenue
of $15.00MM vs $6.34MM (up 136.64%) and basic earnings per share
-$0.20 vs -$0.39. For the twelve months ended December 31st, 2016
vs December 31st, 2015, Keryx Biopharmaceuticals reported revenue
of $31.98MM vs $13.68MM (up 133.79%) and basic earnings per share
-$1.52 vs -$1.19. Keryx Biopharmaceuticals is expected to report
earnings on March 7th, 2018. The report will be for the fiscal
period ending December 31st, 2017. The reported EPS for the same
quarter last year was -$0.32. The estimated EPS forecast for the
next fiscal year is -$0.42 and is expected to report on March 7th,
2018.
To read the full Keryx Biopharmaceuticals, Inc. (KERX) report,
download it here:
http://MarketSourceResearch.com/register/?so=KERX
-----------------------------------------
Gannett Co., Inc. (GCI) REPORT OVERVIEW
Gannett Co.'s Recent Financial Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, Gannett Co. reported revenue of $744.27MM
vs $772.32MM (down 3.63%) and basic earnings per share $0.20 vs
-$0.21. For the twelve months ended December 31st, 2016 vs December
31st, 2015, Gannett Co. reported revenue of $3,047.47MM vs
$2,885.01MM (up 5.63%) and basic earnings per share $0.45 vs $1.27
(down 64.57%). Gannett Co. is expected to report earnings on
February 8th, 2018. The report will be for the fiscal period ending
December 31st, 2017. The reported EPS for the same quarter last
year was $0.50. The estimated EPS forecast for the next fiscal year
is $0.85 and is expected to report on February 8th, 2018.
To read the full Gannett Co., Inc. (GCI) report, download it
here:
http://MarketSourceResearch.com/register/?so=GCI
-----------------------------------------
ABOUT Market Source Research
Market Source Research delivers the key research
reports that helps serious investors, registered brokers,
professional traders, and personal investment advisers find
reliable information in today's markets. Market Source Research's
team is comprised of financial professionals, many of which hold
Chartered Financial Analyst® (CFA®) designations and FINRA®
BrokerCheck® certifications. Whether identifying emerging trends,
or discovering new opportunity, the team at Market Source Research
is dedicated to providing accurate, informative, and objective
content that's ahead of the curve. With insights on individual
companies as well as sectors, readers get the industry's best
available combination of big-picture perspective as well as
granular detail.
REGISTERED MEMBER STATUS
Market Source Research's oversight and audit
staff are registered analysts, brokers, and/or financial advisers
("Registered Members") working within Equity Research, Media, and
Compliance departments. Market Source Research's roster includes
qualified CFA® charterholders, licensed securities attorneys, and
registered FINRA® members holding duly issued CRD® numbers. Current
licensed status of several Registered Members at Market Source
Research have been independently verified by an outside audit firm,
including policy and audit records duly executed by Registered
Members. Complaints, concerns, questions, or inquiries regarding
this release should be directed to Market Source Research's
Compliance department by Phone, at +1 (704) 343-6361, or by E-mail
at compliance@MarketSourceResearch.com.
LEGAL NOTICES
Information contained herein is not an offer or
solicitation to buy, hold, or sell any security. Market Source
Research, Market Source Research members, and/or Market Source
Research affiliates are not responsible for any gains or losses
that result from the opinions expressed. Market Source Research
makes no representations as to the completeness, accuracy, or
timeliness of the material provided and all materials are subject
to change without notice. Market Source Research has not been
compensated for the publication of this press release by any of the
above mentioned companies. Market Source Research is not a
financial advisory firm, investment adviser, or broker-dealer, and
does not undertake any activities that would require such
registration. For our full disclaimer, disclosure, and terms of
service please visit our website.
Media Contact: Hugo Moreau, Media Department
Office: +1 (704) 343-6361 E-mail:
media@MarketSourceResearch.com
© 2017 Market Source Research. All Rights Reserved. For
republishing permissions, please contact a partner network manager
at partnership@MarketSourceResearch.com.
CFA® and Chartered Financial Analyst® are registered
trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks
owned by Financial Industry Regulatory Authority, Inc.
New Gannett (NYSE:GCI)
Historical Stock Chart
From Aug 2024 to Sep 2024
New Gannett (NYSE:GCI)
Historical Stock Chart
From Sep 2023 to Sep 2024